A new venture firm, OMX Ventures, is out of stealth with its first $150 million fund, the backing of the billionaire Merieux family, and 15 investments in bio-engineering startups.
Amid a pandemic implosion, these startups showcase the strength, diversity and adaptability of America’s entrepreneurs—and provide hope for the country’s economic future.
Covid-19 data is voluminous but unwieldy. So tech entrepreneur Tom Siebel combined 32 datasets (and counting) into a massive compendium that researchers could access for free. So far, it’s got 2,000 active users.
Covid-19 is shaking up how patients and insurers alike view telemedicine. Tech-enabled pharmacy startup raised $25 million from Optum Ventures and others to take advantage of that shift.
For the sixth year in a row, Forbes, in partnership with TrueBridge Capital Partners, has searched the country for the next unicorns. In a tough year, these 25 fast-growing companies stand out.
Forbes Under 30 alum Sajith Wickramasekara scores an $850 million valuation for his biotech R&D startup Benchling. Amid the coronavirus pandemic, the company is helping big biotech companies work on potential therapeutics and vaccines for Covid-19.